Линдін, Микола СергійовичЛындин, Николай СергеевичLyndin, Mykola SerhiiovychМоскаленко, Роман АндрійовичМоскаленко, Роман АндреевичMoskalenko, Roman AndriiovychРоманюк, Анатолій МиколайовичРоманюк, Анатолий НиколаевичRomaniuk, Anatolii MykolaiovychSinger, B.B.2019-12-142019-12-142019Prognostic value of CEACAM1 in breast cancer in situ / M. Lyndin, R. Moskalenko, A. Romaniuk et al. // Virchows Archiv. European Journal of Pathology. – 2019. – Vol. 475, Suppl 1. – S. 86. – Pathology is Nice: 31th European Congress of Pathology, 7-11 September 2019, Nice Acropolis Centre, France.0000-0003-4385-39030000-0003-2560-13820000-0002-2342-0337http://essuir.sumdu.edu.ua/handle/123456789/75201Background & Objectives: Ductal breast cancer can be divided into invasive and non-invasive types (cancer in situ – DCIS). Although there is information about molecular features of these tumours, DCIS remains none fully described pathology. Thus we need to find novel reliable diagnostic markers. One could be the сarcinoembryonic antigen related cell adhesion molecules 1 (CEACAM1). This molecule was described in diverse invasive types of cancers. The aim our study presented here was to characterise the exact expression pattern of CEACAM1 in various types of DCIS.encneCEACAM1рак молочної залозирак молочной железыbreast cancerрак in situcancer in situDCISTheses